Australia markets closed

Kaleido Biosciences, Inc. (KLDO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 03:24PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
Total revenue
1,104
1,104
975
Operating expenses
Research development
67,803
67,803
55,967
Selling general and administrative
20,968
20,968
23,882
Total operating expenses
88,771
88,771
79,849
Operating income or loss
-87,667
-87,667
-78,874
Interest expense
2,838
2,838
2,802
Total other income/expenses net
145
145
-193
Income before tax
-90,288
-90,288
-81,620
Income from continuing operations
-90,288
-90,288
-81,620
Net income
-90,288
-90,288
-81,620
Net income available to common shareholders
-90,288
-90,288
-81,620
Basic EPS
-2.16
-
-2.44
Diluted EPS
-2.16
-
-2.44
Basic average shares
41,860
-
33,450
Diluted average shares
41,860
-
33,450